Baidu
map

Ann Surg Oncol:天津医科大总医院董喜凤等荟萃分析发现EBUS-TBNA是诊断可疑肺癌的可靠方法

2013-09-18 佚名 丁香园

支气管内超声引导下经支气管针吸活检术(EBUS-TBNA)在临床较为常用,为了对该项检查的敏感性与特异性加以评估,来自我国天津医科大学总医院血液肿瘤科的董喜凤及其同事开展了一项研究,研究结果发表于2013年8月28日出版的《胸外科年鉴》(Ann Thorac Surg)杂志上。研究结果显示:对于可疑的肺癌患者而言,EBUS-TBNA是一项极具潜力的检查。其对于此类患者中非小细胞肺癌的研究、诊断、及

支气管内超声引导下经支气管针吸活检术(EBUS-TBNA)在临床较为常用,为了对该项检查的敏感性与特异性加以评估,来自我国天津医科大学总医院血液肿瘤科的董喜凤及其同事开展了一项研究,研究结果发表于2013年8月28日出版的《胸外科年鉴》(Ann Thorac Surg)杂志上。研究结果显示:对于可疑的肺癌患者而言,EBUS-TBNA是一项极具潜力的检查。其对于此类患者中非小细胞肺癌的研究、诊断、及分期等,具有很好的敏感性及特异性。【原文下载

该研究是针对相关文献所进行的一项荟萃性分析。研究者通过搜索MEDLINE、EMBASE、和Web of Science数据库,确定了最近10年发表的相关研究文献。作为唯一的侵入性微创检查,这些文献中的受试者均接受了EBUS-TBNA检查,其中部分患者还进行了电子计算机断层扫描(CT)、及正电子发射断层扫描(PET)检查。

该研究的主要结果为:研究者将搜索到的9篇文献纳入了分析,共涉及相关患者1066例。EBUS-TBNA检查在这些患者中的总体敏感性、特异性、阳性预测值、及阴性预测值等,分别为0.90、0.99、0.99、和0.93.相关患者对EBUS-TBNA检查均具有很好的耐受性,且无并发症发生。

该研究结果显示:对于可疑的肺癌患者而言,EBUS-TBNA是一项极具潜力的检查。其对于此类患者中非小细胞肺癌的研究、诊断、及分期等,具有很好的敏感性及特异性。

原文下载

Dong X, Qiu X, Liu Q, Jia J.Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Mediastinal Staging of Non-Small Cell Lung Cancer: A Meta-Analysis.Ann Thorac Surg. 2013 Aug 28. pii: S0003-4975(13)01048-5.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864481, encodeId=d02f186448101, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Mar 05 12:11:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930269, encodeId=7a1d19302699d, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri Oct 04 04:11:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923435, encodeId=d33a192343570, content=<a href='/topic/show?id=ef2f52e50d4' target=_blank style='color:#2F92EE;'>#总医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52750, encryptionId=ef2f52e50d4, topicName=总医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Sun Jun 22 06:11:00 CST 2014, time=2014-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836848, encodeId=8817183684812, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Mon Feb 10 21:11:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811505, encodeId=5d3d1811505a6, content=<a href='/topic/show?id=46e888292fb' target=_blank style='color:#2F92EE;'>#董喜凤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88292, encryptionId=46e888292fb, topicName=董喜凤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 27 10:11:00 CST 2014, time=2014-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681258, encodeId=119e1681258b0, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Oct 24 09:11:00 CST 2013, time=2013-10-24, status=1, ipAttribution=)]
    2014-03-05 minlingfeng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864481, encodeId=d02f186448101, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Mar 05 12:11:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930269, encodeId=7a1d19302699d, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri Oct 04 04:11:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923435, encodeId=d33a192343570, content=<a href='/topic/show?id=ef2f52e50d4' target=_blank style='color:#2F92EE;'>#总医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52750, encryptionId=ef2f52e50d4, topicName=总医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Sun Jun 22 06:11:00 CST 2014, time=2014-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836848, encodeId=8817183684812, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Mon Feb 10 21:11:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811505, encodeId=5d3d1811505a6, content=<a href='/topic/show?id=46e888292fb' target=_blank style='color:#2F92EE;'>#董喜凤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88292, encryptionId=46e888292fb, topicName=董喜凤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 27 10:11:00 CST 2014, time=2014-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681258, encodeId=119e1681258b0, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Oct 24 09:11:00 CST 2013, time=2013-10-24, status=1, ipAttribution=)]
    2013-10-04 cy0324
  3. [GetPortalCommentsPageByObjectIdResponse(id=1864481, encodeId=d02f186448101, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Mar 05 12:11:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930269, encodeId=7a1d19302699d, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri Oct 04 04:11:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923435, encodeId=d33a192343570, content=<a href='/topic/show?id=ef2f52e50d4' target=_blank style='color:#2F92EE;'>#总医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52750, encryptionId=ef2f52e50d4, topicName=总医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Sun Jun 22 06:11:00 CST 2014, time=2014-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836848, encodeId=8817183684812, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Mon Feb 10 21:11:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811505, encodeId=5d3d1811505a6, content=<a href='/topic/show?id=46e888292fb' target=_blank style='color:#2F92EE;'>#董喜凤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88292, encryptionId=46e888292fb, topicName=董喜凤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 27 10:11:00 CST 2014, time=2014-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681258, encodeId=119e1681258b0, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Oct 24 09:11:00 CST 2013, time=2013-10-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1864481, encodeId=d02f186448101, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Mar 05 12:11:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930269, encodeId=7a1d19302699d, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri Oct 04 04:11:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923435, encodeId=d33a192343570, content=<a href='/topic/show?id=ef2f52e50d4' target=_blank style='color:#2F92EE;'>#总医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52750, encryptionId=ef2f52e50d4, topicName=总医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Sun Jun 22 06:11:00 CST 2014, time=2014-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836848, encodeId=8817183684812, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Mon Feb 10 21:11:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811505, encodeId=5d3d1811505a6, content=<a href='/topic/show?id=46e888292fb' target=_blank style='color:#2F92EE;'>#董喜凤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88292, encryptionId=46e888292fb, topicName=董喜凤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 27 10:11:00 CST 2014, time=2014-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681258, encodeId=119e1681258b0, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Oct 24 09:11:00 CST 2013, time=2013-10-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1864481, encodeId=d02f186448101, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Mar 05 12:11:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930269, encodeId=7a1d19302699d, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri Oct 04 04:11:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923435, encodeId=d33a192343570, content=<a href='/topic/show?id=ef2f52e50d4' target=_blank style='color:#2F92EE;'>#总医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52750, encryptionId=ef2f52e50d4, topicName=总医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Sun Jun 22 06:11:00 CST 2014, time=2014-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836848, encodeId=8817183684812, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Mon Feb 10 21:11:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811505, encodeId=5d3d1811505a6, content=<a href='/topic/show?id=46e888292fb' target=_blank style='color:#2F92EE;'>#董喜凤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88292, encryptionId=46e888292fb, topicName=董喜凤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 27 10:11:00 CST 2014, time=2014-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681258, encodeId=119e1681258b0, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Oct 24 09:11:00 CST 2013, time=2013-10-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1864481, encodeId=d02f186448101, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Mar 05 12:11:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930269, encodeId=7a1d19302699d, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri Oct 04 04:11:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923435, encodeId=d33a192343570, content=<a href='/topic/show?id=ef2f52e50d4' target=_blank style='color:#2F92EE;'>#总医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52750, encryptionId=ef2f52e50d4, topicName=总医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Sun Jun 22 06:11:00 CST 2014, time=2014-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836848, encodeId=8817183684812, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Mon Feb 10 21:11:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811505, encodeId=5d3d1811505a6, content=<a href='/topic/show?id=46e888292fb' target=_blank style='color:#2F92EE;'>#董喜凤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88292, encryptionId=46e888292fb, topicName=董喜凤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 27 10:11:00 CST 2014, time=2014-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681258, encodeId=119e1681258b0, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Oct 24 09:11:00 CST 2013, time=2013-10-24, status=1, ipAttribution=)]

相关资讯

Ann Thorac Surg:稳定无变化的肺部磨玻璃样病变极有可能是肺癌

肺部磨玻璃样病变(ground glass opacitie GGO)是近年来早期肺癌诊断的一个突破口,针对这一问题,尚无统一结论。近日来自韩国首尔国立大学的Sukki Cho等进行了一项回顾性分析研究,该研究结果表明无变化稳定的GGO病变,有59%的可能为肺癌,该研究结果发表于2013年8月份的胸外科年鉴(The Annals of thoracic surgery)。【

J Biol Chem:HNF6抑制肺癌细胞转移

来自中科院上海生命科学研究院生物化学与细胞生物学研究所的研究人员证实,肝细胞核因子-6 (Hepatocyte nuclear factor-6, HNF-6)通过p53及抑制上皮间质转化,遏制了肺癌细胞迁移和侵袭。相关研究论文发表在9月10日的《生物化学杂志》(JBC)上。【原文下载】 论文的通讯作者是中科院上海生命科学研究院生物化学与细胞生物学研究所的

Ann Thorac Surg:EGFR 突变状态影响I期非小细胞肺癌患者的预后

表皮生长因子激素受体(EGFR)基因突变可以改善晚期非小肺癌(NSCLC)患者的疗效及预后。然而,对于它在早期非小细胞肺癌患者预后中的作用没有得到很好的鉴定。 针对这种情况,来自美国马萨诸塞州总医院和哈佛医学院医学系的Michael Lanuti博士等人进行了一项研究。

JBC:琥珀酸脱氢酶5调控肺癌转移

来自天津医科大学肿瘤医院的研究人员在新研究中证实,琥珀酸脱氢酶5(Succinate dehydrogenase 5,SDH5)调控了(GSK)-3β-β介导的肺癌转移。这一研究发现在线发表在8月27日的《生化化学杂志》(JBC)上。【原文下载】 论文的通讯作者是天津医科大学肿瘤医院的王长利(Changli Wang)教授,其长期从事胸部肿瘤临床外科工作,主要从事肺

PNAS:肺癌抑制关键因子miRNA

研究指出一种称为miR-486的microRNA在多种适体肿瘤中扮演了重要角色,但是其在肺癌中的作用机制尚不清楚; 这项研究表明,miR-486是肺癌治疗中一个具有潜力的肿瘤抑制因子; 研究结果表明这种小分子RNA可以作为肺癌患者的生物标记,用于针对胰岛素生长因子抑制剂治疗的肺癌患者。【原文下载】 来自俄亥俄州立大学综合癌症中心,四川大学华西医院的研究人员公布的一项最

NEJM:新模型可预测肺结节癌变风险

根据《新英格兰医学杂志》(NEJM)9月4日在线发表的一篇报告,对于在使用小剂量计算机断层扫描(LDCT)筛查高危患者时发现的肺结节,可以使用一种新型的具有“极佳”精准性的统计学模型来预测哪些结节有发生癌变的可能;该模型结合了风险计算,这使得快速简单地根据患者及结节的特征算出肺癌风险成为可能,进而可指导临床方案的制订,并由此减少LDCT筛查项目中发病和死亡的风险和成本(N. Engl. J. Me

Baidu
map
Baidu
map
Baidu
map